Vtv Theraptcs Cl A (VTVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VTVT | BMY | AMGN | GILD | REGN |
| Company | Vtv Theraptcs Cl A | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7855 | 79.84 | 245.93 | 62.83 | 600.67 |
| High | 0.7900 | 80.40 | 247.50 | 63.44 | 604.33 |
| Low | 0.7413 | 79.47 | 243.75 | 62.63 | 598.83 |
| Last | 0.7875 | 79.68 | 247.04 | 63.42 | 602.76 |
| Change | -0.0025 | -0.30 | +2.19 | +0.59 | +0.36 |
| % Change | -0.32% | -0.38% | +0.89% | +0.94% | +0.06% |
| Volume | 23,569 | 2,633,369 | 698,269 | 1,754,147 | 108,421 |
| 20-Day Average Volume | 2,306,798 | 13,825,597 | 3,772,972 | 7,994,575 | 840,523 |
| Previous Close | 0.7900 | 79.98 | 244.85 | 62.83 | 602.40 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7193 | 75.74 | 242.88 | 61.54 | 597.82 |
| 20-Day Raw Stochastic | 67.17% | 88.51% | 59.16% | 74.80% | 40.22% |
| 20-Day Relative Strength | 62.12% | 63.09% | 54.10% | 55.46% | 44.91% |
| Weighted Alpha | -65.64 | +26.25 | +4.12 | -8.54 | -2.19 |
| Today's Opinion | 8% Buy | 88% Buy | 72% Buy | 8% Sell | 56% Sell |
| Previous Opinion | 8% Buy | 88% Buy | 72% Buy | 16% Sell | 72% Sell |
| Last Month's Opinion | 100% Sell | 96% Buy | 88% Buy | 24% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.22% since 06/21/22 | +4.05% since 06/21/22 | +3.33% since 06/21/22 | +4.58% since 06/21/22 | +2.14% since 06/21/22 |
| Low | 0.7210 on 06/23/22 | 76.20 on 06/22/22 | 236.90 on 06/22/22 | 60.09 on 06/22/22 | 580.72 on 06/22/22 |
| High | 0.8000 on 06/27/22 | 80.59 on 06/27/22 | 247.50 on 06/28/22 | 63.53 on 06/27/22 | 613.15 on 06/24/22 |
| 1-Month | |||||
| %Chg | +56.10% since 05/27/22 | +4.50% since 05/27/22 | -3.49% since 05/27/22 | -2.35% since 05/27/22 | -13.36% since 05/27/22 |
| Low | 0.5036 on 05/31/22 | 71.71 on 06/16/22 | 229.49 on 06/17/22 | 57.17 on 06/14/22 | 538.01 on 06/14/22 |
| High | 0.9300 on 06/01/22 | 80.59 on 06/27/22 | 257.97 on 06/01/22 | 65.34 on 06/01/22 | 692.80 on 05/31/22 |
| 3-Month | |||||
| %Chg | +12.07% since 03/28/22 | +8.84% since 03/28/22 | +2.44% since 03/28/22 | +6.93% since 03/28/22 | -13.43% since 03/28/22 |
| Low | 0.3820 on 05/19/22 | 71.71 on 06/16/22 | 227.32 on 05/02/22 | 57.17 on 06/14/22 | 538.01 on 06/14/22 |
| High | 0.9300 on 06/01/22 | 80.59 on 06/27/22 | 258.45 on 04/11/22 | 65.46 on 05/26/22 | 747.42 on 04/08/22 |
| 6-Month | |||||
| %Chg | -16.62% since 12/28/21 | +27.62% since 12/28/21 | +9.11% since 12/28/21 | -13.28% since 12/28/21 | -5.98% since 12/28/21 |
| Low | 0.3820 on 05/19/22 | 60.86 on 01/06/22 | 214.39 on 02/24/22 | 57.17 on 06/14/22 | 538.01 on 06/14/22 |
| High | 1.0400 on 01/04/22 | 80.59 on 06/27/22 | 258.45 on 04/11/22 | 74.12 on 12/30/21 | 747.42 on 04/08/22 |
| Key Statistics | |||||
| Market Capitalization, $K | 71,129 | 170,282,544 | 130,798,880 | 78,808,488 | 65,383,896 |
| Shares Outstanding, K | 90,037 | 2,129,064 | 534,200 | 1,254,313 | 108,539 |
| Annual Sales | 4,010,000 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 16,071,700,000 |
| Annual Net Income | -12,990,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 8,075,300,000 |
| Last Quarter Sales | 2,000,000 | 11,648,000,000 | 6,238,000,000 | 6,590,000,000 | 2,965,100,000 |
| Last Quarter Net Income | -7,010,000 | 1,278,000,000 | 1,476,000,000 | 19,000,000 | 973,500,000 |
| 60-Month Beta | -1.41 | 0.49 | 0.57 | 0.37 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 05/12/22 | 1.96 on 04/29/22 | 4.25 on 04/27/22 | 2.12 on 04/28/22 | 11.49 on 05/04/22 |
| Latest Earnings Date | 08/03/22 | 07/27/22 | 08/02/22 | 08/04/22 | 08/04/22 |
| Most Recent Dividend | N/A | 0.540 on 03/31/22 | 1.940 on 05/16/22 | 0.730 on 06/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 06/30/22 | 05/16/22 | 06/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 10.23 | 13.89 | 8.61 | 7.80 |
